Co-expression of AKT/NICD with control shRNA caused the appearance of multiple focal neoplasms as early as 3 weeks after injection (Fig. 4b and Supplementary Fig. 4b), in line with previous evidence66. The gene discussed is AKT1; the disease is neoplasm.